Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
ITGB3 Biologics Sequence Review Report 2026: Integrin beta-3 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of ITGB3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD4 Biologics Sequence Review Report 2026: T-cell surface glycoprotein CD4 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of CD4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
TLR3 Biologics Sequence Review Report 2026: Toll-like receptor 3 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of TLR3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CXCL1 Biologics Sequence Review Report 2026: Growth-regulated alpha protein Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of CXCL1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
IL3 Biologics Sequence Review Report 2026: Interleukin-3 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of IL3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
FGF4 Biologics Sequence Review Report 2026: Fibroblast growth factor 4 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of FGF4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
ITGBL1 Biologics Sequence Review Report 2026: Integrin beta-like protein 1 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of ITGBL1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
TNFRSF21 Biologics Sequence Review Report 2026: Tumor necrosis factor receptor superfamily member 21 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of TNFRSF21 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GPR37L1 Biologics Sequence Review Report 2026: G protein-coupled receptor 37-like 1 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GPR37L1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
FGF1 Biologics Sequence Review Report 2026: Fibroblast growth factor 1 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of FGF1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
ITGA10 Biologics Sequence Review Report 2026: Integrin alpha-10 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of ITGA10 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GPR39 Biologics Sequence Review Report 2026: G protein-coupled receptor 39 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GPR39 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
195
196
197
198
199
>>
1503
>